Newsroom
Spotlight Story
UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity
Read more
Press Releases
UCB’s HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness…
Read More
UCB extends its BIMZELX® “Get Yourself Back” direct-to-consumer campaign for the hidradenitis…
Read More
Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by…
Read More
UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity
Read More
BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of…
Read More
UCB presents latest research across leading neurology portfolio at American Academy of Neurology (…
Read MoreUCB Stories
Beyond Awareness: Uniting for a Brighter Future at the HS Summit
Read More
Strength in Connection: The Role of Supportive Networks in Psoriatic Disease
Read More
Building Talent, Shaping Futures: Why Interns Matter
Read More
UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder
Read More
UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial…
Read More
